Jessica Hagen

Angle Health raises $134 million, and Trial Library secures $10 million.

Charles N. Kahn III, president and CEO of the Federation of American Hospitals and cofounder of Future of Health, discusses inconsistent and diminishing federal data collection and the urgent need to rebuild trust in the public health sector.

Industry leaders say 2025 marked AI’s shift from hype to practical impact, though the technology remains unready for full-scale adoption and ongoing concerns about ethics and bias persist.

The company said the acquisition allows it to begin delivering a comprehensive stepped care model that incorporates group therapy and peer support.

The company closed after failing to secure additional investment due to regulatory uncertainty and delayed action on extending the Acute Hospital Care at Home Waiver Program.

Dr. Ronald Whelan, CEO of South Africa's Discovery Health, discusses how the insurer uses a shared-value model supported by wearables, data and rewards to incentivize healthier habits.

ACCESS is a decade-long initiative to expand tech-enabled care and outcome-based payments for Medicare patients with obesity, diabetes, chronic pain and depression.

Ciba Health collaborates with Canadian health benefits administrator Quikcard, and Octave Bioscience signs a partnership agreement with Quest Diagnostics.

The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.

Stephen Klasko, executive in residence at General Catalyst, shares how AI, innovation, economic realities and revamped medical training will shape healthcare and longevity.